Welcome to David Evans

We are delighted to welcome David Evans, Investment Director at the Roche Venture Fund to the NMDPharma Board as Non-Executive Director.

David Evans brings over 20 years’ experience in the healthcare industry covering clinical development, market access and health economics, and health-sector policy and financing.

Before joining the Roche Venture Fund, David was at Roche Pharmaceuticals where he led the global data sciences team supporting the neuroscience and rare diseases pipeline. Earlier in his career, David worked at Bristol Myers Squibb and Eli Lilly at global and affiliate levels and, prior to joining the pharmaceutical industry, at the World Bank, with Médecins Sans Frontières, and in clinical medicine. He is a Board Observer with Noema Pharma and Enthera and is involved with multiple other Roche Venture Fund portfolio companies.

David trained in medicine at the University of Sydney, Australia and holds a PhD in clinical epidemiology.

We look forward to having him join us.